Divestments
Biovian
Biovian is a market leader within in contract manufacturing and development of biopharmaceuticals.
Founded in 2003 and based in Turku, Finland, Biovian offers outsourcing services in process development and contract manufacturing for small and medium size biotechnology firms and has deep industry expertise across different key biological processes.
- Sector
Healthcare
- Country
Finland
- Fund
EQT Mid-Market Credit, EQT Mid-Market Credit II
- Entry
2018
- Exit
2020
About Biovian
With main operations in Europe, the US and South Korea, the company benefits from a strong Biotech pipeline, fueled by new biologic products progressively replacing traditional pharma.
EQT Credit provided a Unitranche financing to support Keensight and ERES’ acquisition of Biovian, which is expected to continue to benefit from the attractive growth characteristics of the biopharma market.
Do You Want to Know More?
We are eager to explore how we can achieve great things together.